Kappa opioid receptor is expressed by somatostatin- and neuropeptide Y-containing interneurons in the rat hippocampus

Brain Research

Volumn 931, Issue 1, 2002, Pages 50-55

  Rácz, Bence ^a   Halasy, Katalin ^a  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Double immunocytochemistry; Hippocampus; Interneuron; Neuropeptides; Opioid receptor

Indexed keywords

KAPPA OPIATE RECEPTOR; NEUROPEPTIDE Y; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CHEMICAL LABELING; CONTROLLED STUDY; DENDRITE; HIPPOCAMPUS; IMMUNOREACTIVITY; INTERNEURON; NEUROMODULATION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 0037155464     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02259-X     Document Type: Article

References (38)

1. Evidence for separate projections of hippocampal pyramidal and non-pyramidal neurons to different parts of the septum in the rat brain
2. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist
3. Somatostatin-immunoreactive interneurons contribute to lateral inhibitory circuits in the dentate gyrus of control and epileptic rats
4. Ultrastructural relationships between leu-enkephalin- and GABA-containing neurons differ within the hippocampal formation
5. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus
6. Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy
7. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation
8. Interneurons of the hippocampus
9. Enkephalinergic nerve terminals target inhibitory interneurons in the rat hippocampus
10. Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes
11. Evaluation of neuroprotection and behavioral recovery by the kappa-opioid, PD117302, following transient forebrain ischemia
12. Kappa-opioid receptors also increase potassium conductance
13. Precision and variability in postsynaptic target selection of inhibitory cells in the hippocampal CA3 region
14. Kappa opioid receptors are expressed by interneurons in the CA1 area of the rat hippocampus: A correlated light and electron microscopic immunocytochemical study
15. Subdivisions in the multiple GABAergic innervation of granule cells in the dentate gyrus of the rat hippocampus
16. A high degree of spatial selectivity in the axonal and dendritic domains of physiologically identified local-circuit neurons in the dentate gyrus of the rat hippocampus
17. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients
18. Relationship between hippocampal opioid peptides and seizures
19. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy
20. G-protein-coupled receptor heterodimerization modulates receptor function
21. Co-localization of neuropeptide tyrosine and somatostatin immunoreactivity in neurons of individual subfields of the rat hippocampal region
22. Opioid infidelity: Novel opioid peptides with dual high affinity for delta- and mu-receptors
23. Cholinergic innervation of hippocampal GAD- and somatostatin-immunoreactive commissural neurons
24. Application of the silver-gold intensified 3,3′-diaminobenzidine chromogen to the light and electron microscopic detection of the luteinizing hormone-releasing hormone system of the rat brain
25. A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors
26. Enkephalin blocks inhibitory pathways in the vertebrate CNS
27. Hippocampal dynorphin B injections impair spatial learning in rats: A κ-opioid receptor-mediated effect
28. Kappa-opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats
29. Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential
30. Dynorphin and epilepsy
31. Opioid peptides and receptors. Localization, interactions and relationships to other molecules in the rodent brain, especially the hippocampal formation
32. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons
33. Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent
34. Neuroanatomical patterns of the mu, delta and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography
35. Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: Their immunoreactivity for GABA and projection to the medial septum
36. Ultrasmall gold probes: Characteristics and use in immuno(cyto)chemical studies
37. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus
38. Characterization and visualization of rat and guinea pig brain kappa opioid receptors: Evidence for kappa 1 and kappa 2 opioid receptors